Janus Henderson Horizon Biotechnology A2 S$
Equity
Recent Price
Fund description
The Fund aims to provide capital growth over the long term. The Fund invests at least 80% of its assets in shares (equities) and equity-related securities of companies, which are biotechnology or biotechnology-related, in any country.
Fund Performance
Prices shown are indicative and are usually based on prices of 2-4 dealing days earlier, and may not be exactly the price used for individual trades. Prices and returns on this page may be based on a reference price in a different currency to that of the fund dealing price. Returns experienced by individual clients may differ from those shown below. Clients should not rely on these prices for decision making. Fund prices provided by third-parties. dollarDEX does not guarantee any prices or valuations shown, and accepts no responsibility for their accuracy.
Return
1 week
-2.09
1 month
-1.23
6 months
8.29
1 year
34.87
3 years
Since start *
39.49
Annualized Return %
1 week
1 month
6 months
1 year
34.87
3 years
since start *
39.49
Annual Volatility %
1 week
1 month
6 months
1 year
13.29
3 years
since start *
17.93
Sharpe ratio +
1 week
1 month
6 months
1 year
2.59
3 years
since start *
2.17
*Since start means from start of data available to dollarDEX and may not coincide with inception of fund.
Performance chart
Fund details
Price frequency | Daily |
Pricing basis | Forward |
Dealing basis (subscriptions) What is this? | T+0 |
Dealing basis (redemptions) What is this? | T+0 |
Sector | Healthcare & life sciences |
Asset class | Equity |
Asset sub-class | Mixed |
Region | Global Peer funds |
Dividend distribution option | NA |
Launch price | SGD 10.00 |
Price currency [1] | SGD |
Payment currency | SGD,USD |
Investment type | Cash, SRS |
Risk (volatility) What is this? | Medium High |
Fund annual management & service fee
[2] (built into daily pricing, check prospectus for details) |
1.200% |
Latest bid/NAV price | SGD 24.81 (3-Dec-2024) |
Bid price changes from last available price | -0.08% |
Benchmark | NASDAQ Biotechnology Total Return Index |
Minimum initial investment | SGD 2,500 USD 2,500 |
Minimum subsequent investment | SGD 500 USD 500 |
Minimum RSP investment | SGD 100 USD 100 |
1 Usually same as fund dealing currency (refer to prospectus). Some funds have a SGD reference price used by Navigator.
2 Total of fixed annual management and service fees. Check fund prospectus for details including variable performance fees, if any, which may not be included here.